Overview
Every advance in cancer treatment in recent years has come out of clinical trials — and the physician-scientists at Fred Hutchinson Cancer Center have led the way for decades.
Researchers at Fred Hutch work to develop new, more effective ways to target cancer cells with fewer side effects. The next great breakthroughs are already underway in our labs.
Our clinicians translate these innovations into therapies that patients receive in our clinics. Many of the people providing your day-to-day care may be the same ones leading studies to revolutionize treatment.
Getting breakthroughs to the people who need them
Groundbreaking advances like immunotherapies move “from bench to bedside” — from the labs where they’re developed to the treatment rooms where patients receive them — through a series of studies called clinical trials. These studies test for safety and efficacy, or how effective the treatment is. Often, they compare a new approach to the current standard of care.
At Fred Hutch, we offer you the option to take part in clinical trials that match your specific needs. We have trials for dozens of cancers at every stage as well as many noncancerous blood disorders. Along with investigating new potential treatments, we’re exploring better ways to detect and prevent disease and enhance quality of life for everyone in our care.
Treatment studies give you the chance to be among the first to benefit from a new therapy. This is especially important for patients who have tried every existing option and need something else. For them, our Phase 1 Program offers hope and the knowledge that they are helping future patients. Phase 1 clinical trials are early studies testing new therapies in people for the first time.
We have one of the most active clinical trial programs in the world - providing new hope for our patients every day. The goal of clinical trials is to increase our knowledge about diseases and to develop safer, more effective treatments.
We provide the first academic-based Phase 1 program for cancer research in the Pacific Northwest. The Phase 1 Program provides a full range of research services to advance the development, implementation and successful completion of clinical trials.
Learn more about our clinical trials in our Patient Guide to Clinical Trials, which addresses many of the questions you may have. Who are they for? Are they safe? What kind of clinical trials are there? How do I decide to participate?
